Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations – a PEARRL review

Author:

Price Daniel J12ORCID,Ditzinger Felix34ORCID,Koehl Niklas J5,Jankovic Sandra34ORCID,Tsakiridou Georgia67,Nair Anita1,Holm René8,Kuentz Martin4,Dressman Jennifer B2,Saal Christoph1

Affiliation:

1. Merck KGaA, Darmstadt, Germany

2. Frankfurt Goethe University, Frankfurt, Germany

3. Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland

4. Institute of Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, Muttenz, Switzerland

5. School of Pharmacy, University College Cork, Cork, Ireland

6. Pharmathen SA, Product Design & Evaluation, Athens, Greece

7. Department of Pharmacy, University of Athens, Athens, Greece

8. Drug Product Development, Janssen Research and Development, Johnson and Johnson, Beerse, Belgium

Abstract

Abstract Objectives Supersaturating formulations hold great promise for delivery of poorly soluble active pharmaceutical ingredients (APIs). To profit from supersaturating formulations, precipitation is hindered with precipitation inhibitors (PIs), maintaining drug concentrations for as long as possible. This review provides a brief overview of supersaturation and precipitation, focusing on precipitation inhibition. Trial-and-error PI selection will be examined alongside established PI screening techniques. Primarily, however, this review will focus on recent advances that utilise advanced analytical techniques to increase mechanistic understanding of PI action and systematic PI selection. Key findings Advances in mechanistic understanding have been made possible by the use of analytical tools such as spectroscopy, microscopy and mathematical and molecular modelling, which have been reviewed herein. Using these techniques, PI selection can be guided by molecular rationale. However, more work is required to see widespread application of such an approach for PI selection. Summary Precipitation inhibitors are becoming increasingly important in enabling formulations. Trial-and-error approaches have seen success thus far. However, it is essential to learn more about the mode of action of PIs if the most optimal formulations are to be realised. Robust analytical tools, and the knowledge of where and how they can be applied, will be essential in this endeavour.

Funder

European Union's Horizon 2020 Research and Innovation Programme

Publisher

Oxford University Press (OUP)

Subject

Pharmaceutical Science,Pharmacology

Reference186 articles.

1. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs;Krishnaiah;J Bioequiv Bioavailab,2010

2. Selection of oral bioavailability enhancing formulations during drug discovery;Zheng;Drug Dev Ind Pharm,2012

3. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm Res,1995

4. Poor aqueous solubility – an industry-wide problem in drug discovery;Lipinski;Am Pharm Rev,2002

5. Drug-like properties and the causes of poor solubility and permeability;Lipinski;J Pharmacol Toxicol Methods,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3